1. Market Research
  2. > Healthcare Market Trends
  3. > Enteral Feeding Formulas Market by Product, by Stage, by Application, by End User - Global Forecast to 2020

The global enteral feeding formulas market is expected to grow at a CAGR of 7.6% during the forecast period of 2015-2020 and is estimated to be worth USD 5.95 billion by 2020. The market is mainly driven by factors such as rising incidences of chronic diseases and disorders, rapidly growing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare. However, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some restraints for the growth of the enteral feeding formulas market.

In this report, the global enteral feeding formulas market is segmented by product, stage, application, end user, and region.

On the basis of products, the market is classified into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric and monomeric formulas. The disease-specific formulas included in this report are subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the enteral feeding formulas market is segmented into adults and pediatrics. On the basis of applications, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. By end user, the enteral feeding formulas market is segmented into hospitals and long-term care facilities. Long-term care facilities are further segmented into homecare agencies & hospices and nursing homes and assisted living facilities.

Geographically, North America accounted for the largest share of the global enteral feeding formulas market in 2015, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The Asia-Pacific region is expected to record the highest market growth during the forecast period due to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in emerging APAC countries.

In 2015, Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany) were the leading players in the enteral feeding formulas market.

Reasons to Buy the Report
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the enteral feeding formulas market. The report analyzes the enteral feeding formulas market by stage, product, application, and end user across all regions
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and new product launches in the enteral feeding formulas market
- Market Development: Comprehensive information of the lucrative emerging markets by stage, product, application, end user, and region
- Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the global enteral feeding formulas market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of the leading players in the global enteral feeding formulas market

Table Of Contents

Enteral Feeding Formulas Market by Product, by Stage, by Application, by End User - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 21
1.4 CURRENCY 22
1.5 STAKEHOLDERS 22
2 RESEARCH METHODOLOGY 23
2.1 RESEARCH APPROACH 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.4.1 KEY DATA FROM SECONDARY SOURCES 28
2.4.2 KEY DATA FROM PRIMARY SOURCES 29
2.4.3 KEY INDUSTRY INSIGHTS FROM PRIMARY SOURCES 30
2.4.4 ASSUMPTION FOR THE STUDY 30
3 EXECUTIVE SUMMARY 31
4 PREMIUM INSIGHTS 39
4.1 ENTERAL FEEDING FORMULAS MARKET OVERVIEW 39
4.2 ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION 40
4.3 GEOGRAPHIC SNAPSHOT OF THE ENTERAL FEEDING FORMULAS MARKET 41
4.4 NORTH AMERICA TO DOMINATE THE ENTERAL FEEDING FORMULAS MARKET DURING THE FORECAST PERIOD 42
4.5 ENTERAL FEEDING FORMULAS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 44
5.2 MARKET SEGMENTATION 44
5.2.1 BY STAGE 44
5.2.2 BY PRODUCT 44
5.2.3 BY APPLICATION 45
5.2.4 BY END USER 45
5.3 MARKET DYNAMICS 46
5.3.1 MARKET DRIVERS 46
5.3.1.1 Rising geriatric population across the globe 47
5.3.1.2 High prevalence of chronic diseases and disorders 47
5.3.1.3 Increasing healthcare expenditure 48
5.3.1.4 Growing number of preterm births 48
5.3.1.5 Increasing demand for homecare 50
5.3.2 MARKET RESTRAINTS 50
5.3.2.1 Complications associated with enteral feeding 50
5.3.2.2 Patient safety risks and occurrence of feeding/medication errors associated with enteral feeding devices 51
5.3.3 MARKET OPPORTUNITIES 51
5.3.3.1 Growth in healthcare expenditure of emerging economies 52
5.3.3.2 Increasing demand for personalized medicine 52
5.3.4 MARKET CHALLENGES 53
5.3.4.1 Insufficient reimbursements 53
6 INDUSTRY INSIGHTS 54
6.1 INTRODUCTION 54
6.2 INDUSTRY TRENDS 54
6.2.1 SHIFT FROM PARENTERAL TO ENTERAL NUTRITION 54
6.2.2 MICROENCAPSULATION 54
6.3 STRATEGIC BENCHMARKING 55
6.3.1 PRODUCT PORTFOLIO ANALYSIS: ENTERAL FEEDING FORMULAS MARKET 55
6.4 REGULATORY AND REIMBURSEMENT SCENARIO 56
6.4.1 REGULATORY ANALYSIS 56
6.4.2 REIMBURSEMENT ANALYSIS 57
7 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY STAGE 58
7.1 INTRODUCTION 59
7.2 ADULTS 60
7.3 PEDIATRICS 61
8 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT 64
8.1 INTRODUCTION 65
8.2 STANDARD FORMULAS 66
8.2.1 POLYMERIC FORMULAS 68
8.2.2 MONOMERIC FORMULAS 69
8.3 DISEASE-SPECIFIC FORMULAS 70
8.3.1 DIABETIC FORMULAS 72
8.3.2 RENAL FORMULAS 73
8.3.3 HEPATIC FORMULAS 74
8.3.4 PULMONARY FORMULAS 75
8.3.5 OTHER FORMULAS 76

9 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION 78
9.1 INTRODUCTION 79
9.2 ONCOLOGY 80
9.3 GASTROENTEROLOGY 83
9.4 NEUROLOGY 85
9.5 DIABETES 86
9.6 CRITICAL CARE 88
9.7 OTHER APPLICATIONS 89
10 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY END USER 91
10.1 INTRODUCTION 92
10.2 HOSPITALS 93
10.3 LONG-TERM CARE FACILITIES 95
10.3.1 HOME CARE AGENCIES AND HOSPICES 97
10.3.2 NURSING HOMES 98
10.3.3 ASSISTED LIVING FACILITIES 100
11 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY REGION 102
11.1 INTRODUCTION 103
11.2 NORTH AMERICA 104
11.2.1 U.S. 109
11.2.2 CANADA 114
11.3 EUROPE 119
11.3.1 GERMANY 123
11.3.2 FRANCE 128
11.3.3 U.K. 132
11.3.4 ITALY 137
11.3.5 SPAIN 141
11.3.6 REST OF EUROPE 146
11.4 ASIA-PACIFIC 150
11.4.1 JAPAN 155
11.4.2 CHINA 159
11.4.3 INDIA 164
11.4.4 REST OF ASIA-PACIFIC 169
11.5 REST OF THE WORLD 173
11.5.1 LATIN AMERICA 177
11.5.2 MIDDLE EAST AND AFRICA 181

12 COMPETITIVE LANDSCAPE 186
12.1 OVERVIEW 186
12.2 MARKET SHARE ANALYSIS 187
12.3 COMPETITIVE SITUATION AND TRENDS 188
12.3.1 NEW PRODUCT LAUNCHES 189
12.3.2 EXPANSIONS 190
12.3.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 191
12.3.4 ACQUISITIONS 192
13 COMPANY PROFILES 193
13.1 INTRODUCTION 193
13.2 ABBOTT LABORATORIES 194
13.3 NESTLÉ S.A. 197
13.4 DANONE S.A. 201
13.5 FRESENIUS KABI AG 205
13.6 MEAD JOHNSON NUTRITION COMPANY 208
13.7 B. BRAUN MELSUNGEN AG 211
13.8 HORMEL FOODS CORPORATION 213
13.9 MEIJI HOLDINGS CO., LTD., 215
13.10 VICTUS, INC. 217
13.11 GLOBAL HEALTH PRODUCTS, INC. 218
*Details On Financials, Products and Services, Key Strategy, and Recent Developments Might Not Be Captured In Case Of Unlisted Companies.
14 APPENDIX 219
14.1 INSIGHTS OF INDUSTRY EXPERTS 219
14.2 DISCUSSION GUIDE 220
14.3 AVAILABLE CUSTOMIZATIONS 223
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 224
14.5 RELATED REPORTS 225


LIST OF TABLES

TABLE 1 ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2015 VS. 2020 32
TABLE 2 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING 51
TABLE 3 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 59
TABLE 4 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR ADULTS, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 61
TABLE 5 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR PEDIATRICS,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 63
TABLE 6 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 65
TABLE 7 GLOBAL STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 67
TABLE 8 GLOBAL STANDARD FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 67
TABLE 9 GLOBAL POLYMERIC FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 68
TABLE 10 GLOBAL MONOMERIC FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 69
TABLE 11 GLOBAL DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 71
TABLE 12 GLOBAL DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 71
TABLE 13 GLOBAL DIABETIC FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 72
TABLE 14 GLOBAL RENAL FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 74
TABLE 15 GLOBAL RENAL FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 75
TABLE 16 GLOBAL PULMONARY FORMULAS MARKET SIZE, BY COUNTRY/REGION,
2013-2020 (USD MILLION) 76
TABLE 17 GLOBAL OTHER DISEASE-SPECIFIC FORMULAS MARKET SIZE,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 77
TABLE 18 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 80
TABLE 19 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR ONCOLOGY,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 82
TABLE 20 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR GASTROENTEROLOGY, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 84
TABLE 21 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR NEUROLOGY,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 86
TABLE 22 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR DIABETES,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 88
TABLE 23 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR CRITICAL CARE,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 89
TABLE 24 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 90
TABLE 25 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 92
TABLE 26 U.S.: NUMBER OF HOSPITAL DISCHARGES FOR CHRONIC DISEASES AND DISORDERS, 2013 93
TABLE 27 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR HOSPITALS,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 94
TABLE 28 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 96
TABLE 29 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 96
TABLE 30 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR HOME CARE and HOSPICES, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 98
TABLE 31 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR NURSING HOMES,
BY COUNTRY/REGION, 2013-2020 (USD MILLION) 99
TABLE 32 GLOBAL ENTERAL FEEDING FORMULAS MARKET SIZE FOR ASISTED LIVING FACILITIES, BY COUNTRY/REGION, 2013-2020 (USD MILLION) 101
TABLE 33 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION) 106
TABLE 34 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 107
TABLE 35 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 107
TABLE 36 NORTH AMERICA: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 107
TABLE 37 NORTH AMERICA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 108
TABLE 38 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 108
TABLE 39 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION) 109
TABLE 40 NORTH AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 109
TABLE 41 U.S.: MARKET INDICATORS 110
TABLE 42 U.S.: CHRONIC DISEASES AND DISORDERS STATISTICS 110
TABLE 43 U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 111
TABLE 44 U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 112
TABLE 45 U.S.: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 112
TABLE 46 U.S.: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 112
TABLE 47 U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 113
TABLE 48 U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 113
TABLE 49 U.S.: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 114
TABLE 50 CANADA: MARKET INDICATORS 114
TABLE 51 CANADA: CHRONIC DISEASES AND DISORDERS STATISTICS 115
TABLE 52 CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 116
TABLE 53 CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 116
TABLE 54 CANADA: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 116
TABLE 55 CANADA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 117
TABLE 56 CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 117
TABLE 57 CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 118
TABLE 58 CANADA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 118
TABLE 59 EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 120
TABLE 60 EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 120
TABLE 61 EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 121
TABLE 62 EUROPE: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 121
TABLE 63 EUROPE: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 121
TABLE 64 EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 122
TABLE 65 EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 122
TABLE 66 EUROPE: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 123
TABLE 67 GERMANY: MARKET INDICATORS 123
TABLE 68 GERMANY: CHRONIC DISEASES AND DISORDERS STATISTICS 124
TABLE 69 GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 125
TABLE 70 GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 125
TABLE 71 GERMANY: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 125
TABLE 72 GERMANY: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 126
TABLE 73 GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 126
TABLE 74 GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 127
TABLE 75 GERMANY: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 127
TABLE 76 FRANCE: MARKET INDICATORS 128
TABLE 77 FRANCE: CHRONIC DISEASES AND DISORDERS STATISTICS 128
TABLE 78 FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 129
TABLE 79 FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 130
TABLE 80 FRANCE: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 130
TABLE 81 FRANCE: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 130
TABLE 82 FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 131
TABLE 83 FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 131
TABLE 84 FRANCE: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 132
TABLE 85 U.K.: MARKET INDICATORS 132
TABLE 86 U.K.: CHRONIC DISEASES AND DISORDERS STATISTICS 133
TABLE 87 U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 134
TABLE 88 U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 134
TABLE 89 U.K.: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 134
TABLE 90 U.K.: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 135
TABLE 91 U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 135
TABLE 92 U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 136
TABLE 93 U.K.: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 136
TABLE 94 ITALY: MARKET INDICATORS 137
TABLE 95 ITALY: CHRONIC DISEASES AND DISORDERS STATISTICS 137
TABLE 96 ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 138
TABLE 97 ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 139
TABLE 98 ITALY: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 139
TABLE 99 ITALY: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 139
TABLE 100 ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 140
TABLE 101 ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 140
TABLE 102 ITALY: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 141
TABLE 103 SPAIN: MARKET INDICATORS 141
TABLE 104 SPAIN: CHRONIC DISEASES AND DISORDERS STATISTICS 142
TABLE 105 SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 142
TABLE 106 SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 143
TABLE 107 SPAIN: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 143
TABLE 108 SPAIN: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 144
TABLE 109 SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 144
TABLE 110 SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 145
TABLE 111 SPAIN: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 145
TABLE 112 ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 147
TABLE 113 ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 147
TABLE 114 ROE: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 147
TABLE 115 ROE: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 148
TABLE 116 ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 148
TABLE 117 ROE: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 149
TABLE 118 ROE: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 149
TABLE 119 APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY COUNTRY,
2013-2020 (USD MILLION) 152
TABLE 120 APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 152
TABLE 121 APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 152
TABLE 122 APAC: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 153
TABLE 123 APAC: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 153
TABLE 124 APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 154
TABLE 125 APAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 154
TABLE 126 APAC: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 155
TABLE 127 JAPAN: MARKET INDICATORS 155
TABLE 128 JAPAN: CHRONIC DISEASES AND DISORDERS STATISTICS 156
TABLE 129 JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 157
TABLE 130 JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 157
TABLE 131 JAPAN: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 157
TABLE 132 JAPAN: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 158
TABLE 133 JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 158
TABLE 134 JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 159
TABLE 135 JAPAN: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 159
TABLE 136 CHINA: MARKET INDICATORS 160
TABLE 137 CHINA: CHRONIC DISEASES AND DISORDERS STATISTICS 160
TABLE 138 CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 161
TABLE 139 CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 162
TABLE 140 CHINA: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 162
TABLE 141 CHINA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 162
TABLE 142 CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 163
TABLE 143 CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 163
TABLE 144 CHINA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 164
TABLE 145 INDIA: MARKET INDICATORS 164
TABLE 146 INDIA: CHRONIC DISEASES AND DISORDERS STATISTICS 165
TABLE 147 INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 166
TABLE 148 INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 166
TABLE 149 INDIA: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 166
TABLE 150 INDIA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 167
TABLE 151 INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 167
TABLE 152 INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 168
TABLE 153 INDIA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 168
TABLE 154 ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 170
TABLE 155 ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 170
TABLE 156 ROAPAC: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 170
TABLE 157 ROAPAC: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 171
TABLE 158 ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 171
TABLE 159 ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 172
TABLE 160 ROAPAC: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 172
TABLE 161 ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 173
TABLE 162 ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 173
TABLE 163 ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 174
TABLE 164 ROW: STANDARD FORMULAS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION) 174
TABLE 165 ROW: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 175
TABLE 166 ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 175
TABLE 167 ROW: ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2013-2020 (USD MILLION) 176
TABLE 168 ROW: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 176
TABLE 169 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2013-2020 (USD MILLION) 178
TABLE 170 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 178
TABLE 171 LATIN AMERICA: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 179
TABLE 172 LATIN AMERICA: DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 179
TABLE 173 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 180
TABLE 174 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE,
BY END USER, 2013-2020 (USD MILLION) 180
TABLE 175 LATIN AMERICA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 181
TABLE 176 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE,
BY STAGE, 2013-2020 (USD MILLION) 182
TABLE 177 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 182
TABLE 178 MIDDLE EAST AND AFRICA: STANDARD FORMULAS MARKET SIZE, BY TYPE,
2013-2020 (USD MILLION) 183
TABLE 179 MIDDLE EAST AND AFRICA: DISEASE-SPECIFIC FORMULAS MARKET SIZE,
BY TYPE, 2013-2020 (USD MILLION) 183
TABLE 180 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 184
TABLE 181 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE,
BY END USER, 2013-2020 (USD MILLION) 184
TABLE 182 MIDDLE EAST AND AFRICA: ENTERAL FEEDING FORMULAS MARKET SIZE FOR LONG-TERM CARE FACILITIES, BY TYPE, 2013-2020 (USD MILLION) 185
TABLE 183 GROWTH STRATEGY MATRIX (2012-2015) 188
TABLE 184 NEW PRODUCT LAUNCHES, 2012-2015 189
TABLE 185 EXPANSIONS, 2012-2015 190
TABLE 186 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS, 2012-2015 191
TABLE 187 ACQUISITONS, 2012-2015 192


LIST OF FIGURES

FIGURE 1 ENTERAL FEEDING FORMULAS MARKET 21
FIGURE 2 RESEARCH DESIGN 24
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 4 BOTTOM-UP APPROACH 26
FIGURE 5 TOP-DOWN APPROACH 26
FIGURE 6 DATA TRIANGULATION METHODOLOGY 27
FIGURE 7 ENTERAL FEEDING FORMULAS MARKET SIZE, BY STAGE,
2015 VS. 2020 (USD MILLION) 33
FIGURE 8 ENTERAL FEEDING FORMULAS MARKET SIZE, BY PRODUCT,
2015 VS. 2020 (USD MILLION) 33
FIGURE 9 STANDARD FORMULAS MARKET SIZE, BY TYPE, 2015 VS. 2020 (USD MILLION) 34
FIGURE 10 DISEASE-SPECIFIC FORMULAS MARKET SIZE, BY TYPE,
2015 VS. 2020 (USD MILLION) 35
FIGURE 11 ENTERAL FEEDING FORMULAS MARKET SIZE, BY APPLICATION,
2015 VS. 2020 (USD MILLION) 36
FIGURE 12 ENTERAL FEEDING FORMULAS MARKET SIZE, BY END USER,
2015 VS. 2020 (USD MILLION) 36
FIGURE 13 LONG-TERM CARE FACILITIES MARKET SIZE, BY TYPE,
2015 VS. 2020 (USD MILLION) 37
FIGURE 14 GEOGRAPHIC ANALYSIS: GLOBAL ENTERAL FEEDING FORMULAS MARKET 38
FIGURE 15 RISING PREVALENCE OF CHRONIC DISEASES AND DISORDERS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 39
FIGURE 16 JAPAN IS ESTIMATED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET IN 2015 40
FIGURE 17 U.S. IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL ENTERAL FEEDING FORMULAS MARKET IN 2015 41
FIGURE 18 ENTERAL FEEDING FORMULAS MARKET: GEOGRAPHIC MIX 42
FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD 42
FIGURE 20 ENTERAL FEEDING FORMULAS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
FIGURE 21 GLOBAL ELDERLY POPULATION, BY REGION 47
FIGURE 22 INCREASING GLOBAL HEALTHCARE EXPENDITURE 48
FIGURE 23 PRETERM BIRTH STATISTICS (DEVELOPED COUNTRIES, LATIN AMERICA, AND CARIBBEAN), 1990-2025 49
FIGURE 24 PRETERM BIRTH STATISTICS, BY COUNTRY, 1990-2010 49
FIGURE 25 HEALTHCARE EXPENDITURE GROWTH RATE ACROSS KEY GEOGRAPHIES 52
FIGURE 26 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY STAGE,
2015 VS. 2020 (USD MILLION) 59
FIGURE 27 GLOBAL PREVALENCE OF UNDERWEIGHT CHILDREN, 1990 VS. 2015 62
FIGURE 28 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY PRODUCT,
2015 VS. 2020 (USD MILLION) 65

FIGURE 29 GLOBAL STANDARD FORMULAS MARKET, BY TYPE, 2015 VS. 2020 (USD MILLION) 66
FIGURE 30 GLOBAL DISEASE-SPECIFIC FORMULAS MARKET, BY TYPE,
2015 VS. 2020 (USD MILLION) 70
FIGURE 31 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY APPLICATION,
2015 VS. 2020 (USD MILLION) 79
FIGURE 32 RISING PREVALENCE OF CANCER ACROSS KEY REGIONS FROM 2008 TO 2012 81
FIGURE 33 U.S.: NUMBER OF HOSPITAL DISCHARGES FOR GASTROINTESTINAL TRACT DISEASES (2006-2013) 83
FIGURE 34 GLOBAL POPULATION LIVING WITH DEMENTIA, 2015 85
FIGURE 35 TOP TEN DIABETIC COUNTRIES (20-79 YEARS) IN 2015 87
FIGURE 36 GLOBAL ENTERAL FEEDING FORMULAS MARKET, BY END USER,
2015 VS. 2020 (USD MILLION) 92
FIGURE 37 U.S.: NUMBER OF REGISTERED HOSPITALS (2006-2013) 93
FIGURE 38 GLOBAL ENTERAL FEEDING FORMULAS MARKET FOR LONG-TERM CARE FACILITIES, BY TYPE, 2015 VS. 2020 (USD MILLION) 95
FIGURE 39 U.S.: NUMBER OF HOME CARE AGENCIES (2006-2014) 97
FIGURE 40 U.S.: NUMBER OF NURSING HOMES (2006-2014) 99
FIGURE 41 U.S.: NUMBER OF ASSISTED LIVING FACILITIES (2006-2014) 100
FIGURE 42 GEOGRAPHIC SNAPSHOT (2015-2020): ASIA-PACIFIC, AN EMERGING GROWTH HOTSPOT 103
FIGURE 43 NORTH AMERICAN ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2015 105
FIGURE 44 NORTH AMERICA: HEALTHCARE EXPENDITURE, 2003-2013 106
FIGURE 45 U.S.: HEALTHCARE EXPENDITURE, 2003-2013 111
FIGURE 46 CANADA: HEALTHCARE EXPENDITURE, 2003-2013 115
FIGURE 47 EUROPE: HEALTHCARE EXPENDITURE, 2003-2013 119
FIGURE 48 GERMANY: HEALTHCARE EXPENDITURE, 2003-2013 124
FIGURE 49 FRANCE: HEALTHCARE EXPENDITURE, 2003-2013 129
FIGURE 50 U.K.: HEALTHCARE EXPENDITURE, 2003-2013 133
FIGURE 51 ITALY: HEALTHCARE EXPENDITURE, 2003-2013 138
FIGURE 52 SPAIN: HEALTHCARE EXPENDITURE, 2003-2013 142
FIGURE 53 ROE: HEALTHCARE EXPENDITURE, 2003-2013 146
FIGURE 54 ASIA-PACIFIC ENTERAL FEEDING FORMULAS MARKET SNAPSHOT, 2015 150
FIGURE 55 APAC: HEALTHCARE EXPENDITURE, 2003-2013 151
FIGURE 56 JAPAN: HEALTHCARE EXPENDITURE, 2003-2013 156
FIGURE 57 CHINA: HEALTHCARE EXPENDITURE, 2003-2013 160
FIGURE 58 INDIA: HEALTHCARE EXPENDITURE, 2003-2013 165
FIGURE 59 ROAPAC: HEALTHCARE EXPENDITURE, 2003-2013 169
FIGURE 60 LATIN AMERICA: HEALTHCARE EXPENDITURE, 2003-2013 177
FIGURE 61 MIDDLE EAST AND AFRICA: HEALTHCARE EXPENDITURE, 2003-2013 181
FIGURE 62 NEW PRODUCT LAUNCHES AND EXPANSIONS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS IN THE LAST THREE YEARS
(2012-2015) 186
FIGURE 63 GLOBAL ENTERAL FEEDING FORMULAS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 187

FIGURE 64 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR PLAYERS 193
FIGURE 65 COMPANY SNAPSHOT: ABBOTT LABORATORIES 194
FIGURE 66 COMPANY SNAPSHOT: NESTLÉ S.A. 197
FIGURE 67 COMPANY SNAPSHOT: DANONE S.A. 201
FIGURE 68 COMPANY SNAPSHOT: FRESENIUS KABI AG 205
FIGURE 69 COMPANY SNAPSHOT: MEAD JOHNSON NUTRITION COMPANY 208
FIGURE 70 COMPANY SNAPSHOT: B. BRAUN MELSUNGEN AG 211
FIGURE 71 COMPANY SNAPSHOT: HORMEL FOODS CORPORATION 213
FIGURE 72 COMPANY SNAPSHOT: MEIJI HOLDINGS CO., LTD. 215

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.